Efficacy of Intragastric Balloons in the Markers of Metabolic Dysfunction-associated Fatty Liver Disease: Results from Meta-analyses

BACKGROUND AND AIMS: Nonalcoholic fatty liver disease, now renamed metabolic dysfunction-associated fatty liver disease (MAFLD), is common in obese patients. Intragastric balloon (IGB), an obesity management tool with low complication risk, might be used in MAFLD treatment but there is still unexpla...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Zi-Yuan, Zeng, Jing, Ren, Tian-Yi, Shi, Yi-Wen, Yang, Rui-Xu, Fan, Jian-Gao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: XIA & HE Publishing Inc. 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237142/
https://www.ncbi.nlm.nih.gov/pubmed/34221921
http://dx.doi.org/10.14218/JCTH.2020.00183

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237142/
https://www.ncbi.nlm.nih.gov/pubmed/34221921
http://dx.doi.org/10.14218/JCTH.2020.00183

Ejemplares similares